Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.

Volume 32, Number 6—June 2026

Research

Wickerhamomyces anomalus Fungemia during Healthcare-Associated Outbreak, Pereira, Colombia, 2025

Karen M. Ordoñez1, Diego H. Caceres1Comments to Author , Andres Ceballos-Garzon, Natalia Salazar-Giraldo, Bram Spruijtenburg, Lina M. Velasquez-Orozco, Eelco F.J. Meijer, Gabriel Vinazco, Elaine Cristina Francisco, Rodrigo Oliveira, Patricia Escandon, and Jacques F. Meis
Author affiliation: E.S.E. Hospital Universitario San Jorge de Pereira, Secretaría de Salud de Risaralda, Risaralda, Colombia (K.M. Ordoñez, N. Salazar-Giraldo, L.M. Velasquez-Orozco, G. Vinazco); Immuno-Mycologics, Norman, Oklahoma, USA (D.H. Caceres); Universidad del Rosario, Bogota, Colombia (D.H. Caceres, A. Ceballos-Garzon); Radboudumc-CWZ Center of Expertise for Mycology, Nijmegen, the Netherlands (D.H. Caceres, B. Spruijtenburg, E.F.J. Meijer, J.F. Meis); Canisius-Wilhelmina Hospital (CWZ)/Dicoon, Nijmegen (B. Spruijtenburg, E.F.J. Meijer); Universidade Federal de São Paulo, São Paulo, Brazil (C. Francisco); Antimicrobial Resistance Institute of São Paulo, São Paulo (C. Francisco); Universidade Federal do Paraná, Curitiba, Brazil (C. Francisco, J.F. Meis); Bruker Daltonics GmbH & Co. KG, Bremen, Germany (R. Oliveira); Instituto Nacional de Salud, Bogotá (P. Escandon); University of Cologne, Cologne, Germany (J.F. Meis)

Main Article

Figure 2

Minimum-spanning tree of Wickerhamomyces anomalus genotypes based on short tandem repeat genotyping in study of W. anomalus fungemia during healthcare-associated outbreak, Pereira, Colombia, 2025. Isolates from Colombia are compared with control isolates from Venezuela and Brazil (1,15).

Figure 2. Minimum-spanning tree of Wickerhamomyces anomalus genotypes based on short tandem repeat genotyping in study of W. anomalus fungemia during healthcare-associated outbreak, Pereira, Colombia, 2025. Isolates from Colombia are compared with control isolates from Venezuela and Brazil (1,15).

Main Article

References
  1. Pasqualotto  AC, Sukiennik  TC, Severo  LC, de Amorim  CS, Colombo  AL. An outbreak of Pichia anomala fungemia in a Brazilian pediatric intensive care unit. Infect Control Hosp Epidemiol. 2005;26:553–8. DOIPubMedGoogle Scholar
  2. Francisco  EC, Caceres  DH, Brunelli  JGP, Garcia-Effron  G, Arastehfar  A, Ribeiro  FC, et al. An update on clinically relevant, rare, and emerging Candida and Saccharomycotina yeasts that have been recently reclassified from Candida. Clin Microbiol Rev. 2025;38:e0006423. DOIPubMedGoogle Scholar
  3. Ioannou  P, Baliou  S, Kofteridis  DP. Fungemia by Wickerhamomyces anomalus—a narrative review. Pathogens. 2024;13:269. DOIPubMedGoogle Scholar
  4. Rattani  S, Farooqi  J, Hussain  AS, Jabeen  K. Spectrum and antifungal resistance of Candidemia in neonates with early- and late-onset sepsis in Pakistan. Pediatr Infect Dis J. 2021;40:814–20. DOIPubMedGoogle Scholar
  5. da Silva  CM, de Carvalho Parahym  AM, Leão  MP, de Oliveira  NT, de Jesus Machado Amorim  R, Neves  RP. Fungemia by Candida pelliculosa (Pichia anomala) in a neonatal intensive care unit: a possible clonal origin. Mycopathologia. 2013;175:175–9. DOIPubMedGoogle Scholar
  6. Lin  HC, Lin  HY, Su  BH, Ho  MW, Ho  CM, Lee  CY, et al. Reporting an outbreak of Candida pelliculosa fungemia in a neonatal intensive care unit. J Microbiol Immunol Infect. 2013;46:456–62. DOIPubMedGoogle Scholar
  7. Aragão  PA, Oshiro  IC, Manrique  EI, Gomes  CC, Matsuo  LL, Leone  C, et al.; IRIS Study Group. Pichia anomala outbreak in a nursery: exogenous source? Pediatr Infect Dis J. 2001;20:843–8. DOIPubMedGoogle Scholar
  8. Chakrabarti  A, Singh  K, Narang  A, Singhi  S, Batra  R, Rao  KL, et al. Outbreak of Pichia anomala infection in the pediatric service of a tertiary-care center in Northern India. J Clin Microbiol. 2001;39:1702–6. DOIPubMedGoogle Scholar
  9. Yang  Y, Wu  W, Ding  L, Yang  L, Su  J, Wu  B. Two different clones of Candida pelliculosa bloodstream infection in a tertiary neonatal intensive care unit. J Infect Dev Ctries. 2021;15:870–6. DOIPubMedGoogle Scholar
  10. Zhang  L, Xiao  M, Arastehfar  A, Ilkit  M, Zou  J, Deng  Y, et al. Investigation of the emerging nosocomial Wickerhamomyces anomalus infections at a Chinese tertiary teaching hospital and a systemic review: clinical manifestations, risk factors, treatment, outcomes, and anti-fungal susceptibility. Front Microbiol. 2021;12:744502. DOIPubMedGoogle Scholar
  11. Jung  J, Moon  YS, Yoo  JA, Lim  JH, Jeong  J, Jun  JB. Investigation of a nosocomial outbreak of fungemia caused by Candida pelliculosa (Pichia anomala) in a Korean tertiary care center. J Microbiol Immunol Infect. 2018;51:794–801. DOIPubMedGoogle Scholar
  12. Paccoud  O, Lortholary  O, Imbert  S, Letscher-Bru  V, Boukris-Sitbon  K, Obadia  T, et al.; French Mycoses Study Group. Yeast fungaemia among injection drug users in France (2012–2022): a cross-sectional observational study. Lancet Reg Health Eur. 2025;55:101365. DOIPubMedGoogle Scholar
  13. Clinical and Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of yeasts, 4th ed. CLSI standard M27. Wayne (PA): The Institute; 2017.
  14. Spruijtenburg  B, Rudramurthy  SM, Meijer  EFJ, van Haren  MHI, Kaur  H, Chakrabarti  A, et al. Application of novel short tandem repeat typing for Wickerhamomyces anomalus reveals simultaneous outbreaks within a single hospital. Microorganisms. 2023;11:1525. DOIPubMedGoogle Scholar
  15. Luo  Z, Ning  Y, Xiao  M, Guo  D, Xu  H, Liu  Y, et al. High azole non-wild type rates and nosocomial microsatellite typing aggregation of Wickerhamomyces anomalus in China according to a 12-year multicenter surveillance study. J Antimicrob Chemother. 2025;80:1964–71. DOIPubMedGoogle Scholar
  16. Zhang  Z, Cao  Y, Li  Y, Chen  X, Ding  C, Liu  Y. Risk factors and biofilm formation analyses of hospital-acquired infection of Candida pelliculosa in a neonatal intensive care unit. BMC Infect Dis. 2021;21:620. DOIPubMedGoogle Scholar
  17. Kalenic  S, Jandrlic  M, Vegar  V, Zuech  N, Sekulic  A, Mlinaric-Missoni  E. Hansenula anomala outbreak at a surgical intensive care unit: a search for risk factors. Eur J Epidemiol. 2001;17:491–6. DOIPubMedGoogle Scholar
  18. Thuler  LC, Faivichenco  S, Velasco  E, Martins  CA, Nascimento  CR, Castilho  IA. Fungaemia caused by Hansenula anomala—an outbreak in a cancer hospital. Mycoses. 1997;40:193–6. DOIPubMedGoogle Scholar
  19. Murphy  N, Buchanan  CR, Damjanovic  V, Whitaker  R, Hart  CA, Cooke  RW. Infection and colonisation of neonates by Hansenula anomala. Lancet. 1986;1:291–3. DOIPubMedGoogle Scholar
  20. Franco  MD, Caceres  DH, Carrillo  JFF, Pérez-Guzmán  A, Ceballos-Garzon  A, Briceño  AC, et al. Outbreak of Wickerhamomyces anomalus (formerly Candida pelliculosa) bloodstream infections, Venezuela, 2022–2023. Emerg Infect Dis. 2026;32:XXX–XXX.
  21. Pfaller  MA, Castanheira  M, Diekema  DJ, Messer  SA, Jones  RN. Triazole and echinocandin MIC distributions with epidemiological cutoff values for differentiation of wild-type strains from non-wild-type strains of six uncommon species of Candida. J Clin Microbiol. 2011;49:3800–4. DOIPubMedGoogle Scholar
  22. Verma  S, Tilak  R, Singh  G, Singh  S, Kumari  A, Rudramurthy  SM, et al. Multicentre investigation of Wickerhamomyces anomalus fungemia in India: emerging resistance and mechanistic insights. J Antimicrob Chemother. 2026;81:dkaf420. DOIPubMedGoogle Scholar
  23. Luo  Z, Ning  Y, Dai  R, Ainiwaer  A, Li  Y, Zhang  R, et al. A pan-azole and pan-echinocandin resistant Wickerhamomyces anomalus isolate causing bloodstream infection: ERG11Y140F, K151R with copy number variation and FKS1F665S mutation. Int J Med Microbiol. 2025;321:151689. DOIPubMedGoogle Scholar

Main Article

1These authors share first authorship for this article.

Page created: April 17, 2026
Page updated: May 26, 2026
Page reviewed: May 26, 2026
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external